RETHINC
2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
In 535 symptomatic tobacco-exposed adults with preserved spirometry, indacaterol-glycopyrronium for 12 weeks did not improve respiratory symptoms (SGRQ ≥4-point response) compared with placebo.
Result
- Absolute difference
- 2.6 points
The absolute difference is derived from the event rates.
- Subtopic
- Preserved spirometry
- Design
- Multicentre RCT
- Relevance
- Supporting: context rather than must-know.
- Cited in
- GOLD 2023 COPD
- Source
- Han MK, et al. N Engl J Med. 2022;387(13):1173-1184.doi 10.1056/NEJMoa2204752
Discussion & critique
Spirometry is essential before initiating COPD therapy; bronchodilators do not help symptomatic smokers without airflow obstruction.